Your browser doesn't support javascript.
loading
Reply to 'Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumour response and tolerance' by Funck-Brentano et al.
Goldwirt, L; Chami, I; Feugeas, J-P; Pages, C; Brunet-Possenti, F; Allayous, C; Baroudjian, B; Madelaine, I; Sauvageon, H; Mourah, S; Lebbé, C.
Afiliação
  • Goldwirt L; Department of Pharmacology, AP-HP, Saint-Louis Hospital, Inserm, U976 Université Paris Diderot, Sorbonne Paris Cité, UMR-S-976, Paris lauriane.goldwirt@aphp.fr.
  • Chami I; Department of Dermatology, AP-HP, Saint-Louis Hospital, Paris Inserm, U 976, Paris Faculté de Médecine, Université Paris Diderot, Sorbonne Paris Cité, Paris.
  • Feugeas JP; INSERM, IAME, UMR 1137, Université Paris Diderot, Paris.
  • Pages C; Department of Dermatology, AP-HP, Saint-Louis Hospital, Paris Inserm, U 976, Paris Faculté de Médecine, Université Paris Diderot, Sorbonne Paris Cité, Paris.
  • Brunet-Possenti F; Department of Dermatology, AP-HP, Saint-Louis Hospital, Paris Inserm, U 976, Paris Faculté de Médecine, Université Paris Diderot, Sorbonne Paris Cité, Paris.
  • Allayous C; Department of Dermatology, AP-HP, Saint-Louis Hospital, Paris Inserm, U 976, Paris Faculté de Médecine, Université Paris Diderot, Sorbonne Paris Cité, Paris.
  • Baroudjian B; Department of Dermatology, AP-HP, Saint-Louis Hospital, Paris Inserm, U 976, Paris Faculté de Médecine, Université Paris Diderot, Sorbonne Paris Cité, Paris.
  • Madelaine I; Deparment of Pharmacy, AP-HP, Saint-Louis Hospital, Paris, France.
  • Sauvageon H; Department of Pharmacology, AP-HP, Saint-Louis Hospital, Inserm, U976 Université Paris Diderot, Sorbonne Paris Cité, UMR-S-976, Paris.
  • Mourah S; Department of Pharmacology, AP-HP, Saint-Louis Hospital, Inserm, U976 Université Paris Diderot, Sorbonne Paris Cité, UMR-S-976, Paris.
  • Lebbé C; Department of Dermatology, AP-HP, Saint-Louis Hospital, Paris Inserm, U 976, Paris Faculté de Médecine, Université Paris Diderot, Sorbonne Paris Cité, Paris.
Ann Oncol ; 27(2): 363-4, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26578723
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Sulfonamidas / Proteínas Proto-Oncogênicas B-raf / Indóis / Melanoma / Mutação Limite: Female / Humans / Male Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Sulfonamidas / Proteínas Proto-Oncogênicas B-raf / Indóis / Melanoma / Mutação Limite: Female / Humans / Male Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article